Healthcare5 months ago
Zydus Lifesciences Limited (zyduslife) NDA for Saroglitazar Granted Priority Review by US FDA
Zydus Lifesciences Limited (ZYDUSLIFE) receives US FDA Priority Review for Saroglitazar NDA to treat Primary Biliary Cholangitis (PBC).
